Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Integration of Tumor Transcriptomic, Genomic, and Immune Profiles Reveals Distinct Populations of Low-Grade B-Cell Lymphomas with Poor Outcome

Melissa A. Hopper, Kerstin Wenzl, Keenan T. Hartert, Jordan E. Krull, Joseph P. Novak, Michelle K. Manske, MaKayla R. Serres, Vivekananda Sarangi, Melissa C. Larson, Matthew J. Maurer, Jonas Paludo, Ellen D. McPhail, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Stephen M. Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak

Blood (2021) 138 (Supplement 1): 808.

https://doi.org/10.1182/blood-2021-147363

Published: 2021

Journal Articles

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma

Aishwarya Ravindran, MBBS, Andrew L. Feldman, MD, Rhett P. Ketterling, MD, Surendra Dasari, PhD, Karen Rech, MD, Ellen D. McPhail, MD, Paul J Kurtin, MD, Min Shi, MDPhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134547

Published: 2020

Journal Articles

Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis

Surbhi Sidana, MD, Surendra Dasari, PhD, Taxiarchis Kourelis, MD, Angela Dispenzieri, MD, David L Murray, MD PhD, Rebecca L. King, MD, Ellen D. McPhail, MD, Marina Ramirez-Alvarado, Shaji K. Kumar, MD, Morie A. Gertz, MD

Blood (2019) 134 (Supplement_1): 1770.

https://doi.org/10.1182/blood-2019-121714

Published: 2019

Journal Articles

A Proteomic Atlas of Cardiac Amyloidosis

Taxiarchis Kourelis, MD, Surendra Dasari, PhD, Ahmed U Fayyaz, MD, Martha Grogan, Marina Ramirez-Alvarado, Margaret Redfield, Omar F. abou Ezzeddine, MD, C.M., M.S., Angela Dispenzieri, MD, Ellen D. McPhail, MD

Blood (2019) 134 (Supplement_1): 1790.

https://doi.org/10.1182/blood-2019-124802

Published: 2019

Journal Articles

Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade Lymphomas

Keenan T. Hartert, PhD, Kerstin Wenzl, PhD, Jordan Krull, Michelle Manske, MS, BS, Vivekananda Sarangi, Melissa C Larson, Theodora Anagnostou, MD, Ellen D. McPhail, MD, Brian K. Link, MD, Stephen M Ansell, MD PhD, James R. Cerhan, MD PhD, Dragan Jevremovic, MD PhD, Anne J Novak, PhD

Blood (2019) 134 (Supplement_1): 2764.

https://doi.org/10.1182/blood-2019-128803

Published: 2019

Journal Articles

Plasma Cell Disorders in Patients with Age-Related Transthyretin (ATTRwt) Amyloidosis

M Hasib Sidiqi, MBBS, Shaji K. Kumar, MD, Surendra Dasari, PhD, Ellen D. McPhail, MD, Francis K. Buadi, MB, CHB, Rahma Warsame, MD, Martha Q. Lacy, MD, David Dingli, MD PhD, Wilson I Gonsalves, MD, Prashant Kapoor, MD, Taxiarchis Kourelis, MD, Nelson Leung, MD, Eli Muchtar, MD, John A. Lust, MD PhD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Morie A. Gertz, MD, Angela Dispenzieri, MD

Blood (2018) 132 (Supplement 1): 5610.

https://doi.org/10.1182/blood-2018-99-120058

Published: 2018

Journal Articles

High Level MYC Amplification in Aggressive B-Cell Lymphomas: Is It a Marker of Aggressive Disease?

Priyanka Pophali, MD, Lisa M Marinelli, Rhett P. Ketterling, Reid Gregory Meyer, Ellen D. McPhail, MD, Paul J Kurtin, MD, Thomas M. Habermann, MD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 1693.

https://doi.org/10.1182/blood-2018-99-115484

Published: 2018

Journal Articles

Genetic subtyping of breast implant–associated anaplastic large cell lymphoma

Naoki Oishi, Garry S. Brody, Rhett P. Ketterling, David S. Viswanatha, Rong He, Surendra Dasari, Ming Mai, Hailey K. Benson, Christopher A. Sattler, Rebecca L. Boddicker, Ellen D. McPhail, N. Nora Bennani, Christin A. Harless, Kuldeep Singh, Mark W. Clemens, L. Jeffrey Medeiros, Roberto N. Miranda, Andrew L. Feldman

Blood (2018) 132 (5): 544–547.

https://doi.org/10.1182/blood-2017-12-821868

Published: 2018

Includes: Supplemental data

Journal Articles

Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"

Ellen D. McPhail, MD, Matthew J Maurer, MS, Rhett P. Ketterling, MD, William R. Macon, MD, Andrew L Feldman, MD, Paul J Kurtin, MD, Thomas E. Witzig, MD, Rakhee Vaidya, MD, Thomas M. Habermann, MD

Blood (2016) 128 (22): 1750.

https://doi.org/10.1182/blood.V128.22.1750.1750

Published: 2016

Journal Articles

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Thomas M. Habermann, MD, William R. Macon, MD, Matthew J Maurer, MS, Rhett P. Ketterling, MD, Paul J Kurtin, MD, Andrew L Feldman, MD, Rakhee Vaidya, MD, James R Cerhan, MD PhD, Stephen Ansell, MD PhD, Luis Porrata, MD, Grzegorz S. Nowakowski, MD, Thomas E. Witzig, MD, Ellen D. McPhail, MD

Blood (2016) 128 (22): 155.

https://doi.org/10.1182/blood.V128.22.155.155

Published: 2016

Journal Articles

Everolimus Plus RCHOP-21 Is Safe and Highly Effective for New Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Phase I Trial NCCTG1085 (Alliance)

Patrick B. Johnston, MD PhD, Betsy R. Laplant, MS, Ellen D. McPhail, MD, Thomas M. Habermann, MD, David J. Inwards, MD, Ivana N. Micallef, MD, Joseph P. Colgan, MD, Grzegorz S. Nowakowski, MD, Stephen Ansell, MD PhD, Thomas E. Witzig, MD

Blood (2015) 126 (23): 813.

https://doi.org/10.1182/blood.V126.23.813.813

Published: 2015

Journal Articles

Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma

Luis Porrata, MD, Kay Ristow, Ellen D. McPhail, MD, William Macon, MD, Matthew J Maurer, MS, Grzegorz S. Nowakowski, MD, Stephen Ansell, MD PhD, Thomas E. Witzig, MD, Svetomir Markovic, MD PhD, Thomas M. Habermann, MD

Blood (2015) 126 (23): 3885.

https://doi.org/10.1182/blood.V126.23.3885.3885

Published: 2015

Journal Articles

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Amie E Jackson, MD, Michael Mian, Christina H. Kalpadakis, MD, Gerassimos A Pangalis, MD, Anastasios Stathis, MD, Elena Porro, MSc, Ellen D McPhail, MD, Thomas M Habermann, MD, Kay M. Ristow, Franco Cavalli, MD, Grzegorz S. Nowakowski, MD, Emanuele Zucca, MD

Blood (2014) 124 (21): 1637.

https://doi.org/10.1182/blood.V124.21.1637.1637

Published: 2014

NARROW

Integration of Tumor Transcriptomic, Genomic, and Immune Profiles Reveals Distinct Populations of Low-Grade B-Cell Lymphomas with Poor Outcome

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma

Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis

A Proteomic Atlas of Cardiac Amyloidosis

Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade Lymphomas

Plasma Cell Disorders in Patients with Age-Related Transthyretin (ATTRwt) Amyloidosis

High Level MYC Amplification in Aggressive B-Cell Lymphomas: Is It a Marker of Aggressive Disease?

Genetic subtyping of breast implant–associated anaplastic large cell lymphoma

Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Everolimus Plus RCHOP-21 Is Safe and Highly Effective for New Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Phase I Trial NCCTG1085 (Alliance)

Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only